Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
7.70
-0.34 (-4.23%)
At close: May 21, 2024, 4:00 PM
7.65
-0.05 (-0.65%)
After-hours: May 21, 2024, 7:55 PM EDT

Altimmune Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2005
Revenue
0.43-0.074.418.195.8
Upgrade
Revenue Growth (YoY)
---46.12%41.09%-43.85%
Upgrade
Gross Profit
0.43-0.074.418.195.8
Upgrade
Selling, General & Admin
18.1417.1315.4113.218.5
Upgrade
Research & Development
65.870.5474.5449.7717.77
Upgrade
Other Operating Expenses
12.42011.3701
Upgrade
Operating Expenses
96.3687.67101.3262.9827.27
Upgrade
Operating Income
-95.93-87.74-96.91-54.8-21.46
Upgrade
Interest Expense / Income
0.040.010.010.010
Upgrade
Other Expense / Income
-7.52-2.840.17-0.35-0.89
Upgrade
Pretax Income
-88.45-84.91-97.09-54.46-20.58
Upgrade
Income Tax
0-0.20-5.42-0.06
Upgrade
Net Income
-88.45-84.71-97.09-49.04-20.52
Upgrade
Preferred Dividends
00000.45
Upgrade
Net Income Common
-88.45-84.71-97.09-49.04-20.97
Upgrade
Shares Outstanding (Basic)
5347412613
Upgrade
Shares Outstanding (Diluted)
5347412613
Upgrade
Shares Change
13.47%13.67%61.03%95.33%368.35%
Upgrade
EPS (Basic)
-1.66-1.81-2.35-1.91-1.60
Upgrade
EPS (Diluted)
-1.66-1.81-2.35-1.91-1.60
Upgrade
Free Cash Flow
-75.86-62.71-90.36-34.51-9.6
Upgrade
Free Cash Flow Per Share
-1.43-1.34-2.19-1.35-0.73
Upgrade
Gross Margin
100.00%-100.00%100.00%100.00%
Upgrade
Operating Margin
-22518.54%--2197.60%-669.50%-370.00%
Upgrade
Profit Margin
-20762.21%--2201.59%-599.20%-361.52%
Upgrade
Free Cash Flow Margin
-17806.81%--2048.87%-421.62%-165.53%
Upgrade
EBITDA
-87.94-84.41-96.53-54.02-20.19
Upgrade
EBITDA Margin
-20642.02%--2188.98%-660.02%-348.00%
Upgrade
Depreciation & Amortization
0.480.490.550.430.39
Upgrade
EBIT
-88.41-84.9-97.09-54.45-20.58
Upgrade
EBIT Margin
-20753.99%--2201.47%-665.26%-354.68%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).